Form 4 Tracker
Carl L Gordon

Director; Director, 10% Owner · 6 filings · Latest: Sep 28, 2026

ADARx Pharmaceuticals, Inc.
BlossomHill Therapeutics, Inc.
Electra Therapeutics, Inc.
Scribe Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ADRX
Carl L GordonDirector, 10% OwnerSep 28, 2026
Purchase
$17.00950,000$16.1M588,235
ETRA
Carl L GordonDirector, 10% OwnerSep 21, 2026
Purchase
$15.001,333,333$20.0M1,758,279
BLSM
Carl L GordonDirectorAug 10, 2026
Purchase
$16.00625,000$10.0M2,714,279
SCTX
Carl L GordonDirectorJul 27, 2026
Purchase
$15.001,000,000$15.0M1,348,825